Menu
Not yet recruiting NCT07294248

Role of MRI and US in Superficial Soft Tissue Masses

Observational Superficial Soft Tissue Masses

For patients and families

In plain language

An automatic summary of structured registry data. It is an orientation aid, not a substitute for the official protocol or a physician assessment.

What is being studied
The protocol lists: Diagnostic imaging (US and MRI)..
Who it may be relevant to
Registry conditions: Superficial Soft Tissue Masses. Basic parameters: No limits · All.
What needs checking
Age, condition and sex are only basic indicators. Prior treatment, laboratory values and other mandatory requirements appear in the eligibility criteria below.
Where it takes place
Egypt
Next step
Save the trial, show it to the treating physician, and confirm current recruitment with the study center. Costs, documents and travel →
Official title

Diagnostic Role of Magnetic Resonance Imaging and Ultrasonography in Characterization of Superficial Soft Tissue Masses.

Overview

The goal of this observational study to evaluate the accuracy of Magnetic Resonance Imaging and Ultrasonography in characterization of superficial soft tissue masses.

Detailed description

This study is a prospective observational study aiming to evaluate and compare the diagnostic roles of magnetic resonance imaging (MRI) and ultrasound (US) in the characterization of superficial soft tissue masses. The study will be conducted in \[ Sohag \] over a period of \[ 6 Months\].

Participants Consecutive patients presenting with superficial soft tissue masses (located within the subcutaneous tissue. Inclusion criteria include Patients who suffer from superficial soft tissue lesions measurable by both MRI and US in both sex and of any age group, will be included in the study , Exclusion criteria include Patients unwilling to complete study, Patients with absolute or relative contraindications for imaging including; claustrophobia, metallic implants, pacemaker and prosthetic heart valves for MRI, will be evaluated by US.

Objectives

* Primary objective: To determine the added value of MRI compared with ultrasound in accurate characterization of superficial soft tissue masses (benign vs malignant features). * Secondary objectives: * Assess concordance between MRI and US in differentiating cystic versus solid lesions. * Identify specific imaging features on MRI and US that best predict malignant potential. * Evaluate interobserver agreement for MRI and US interpretations.

Methods Imaging Protocols

* Ultrasound: High-resolution ultrasound with Doppler will be performed to assess size, echotexture, margins, internal septations, vascularity, and presence of calcifications. Lesions will be categorized as solid, cystic, or complex. * MRI: MRI protocols will include T1-weighted, T2-weighted, STIR, and post-contrast sequences, with assessment of lesion margins, internal composition, enhancement pattern, diffusion characteristics where available, and involvement of adjacent structures.

Data Collection and Outcomes

* Demographic data, lesion characteristics (size, location, depth), imaging features, and final diagnosis will be recorded. * Primary outcome: Diagnostic accuracy (sensitivity, specificity, positive and negative predictive values) of MRI and US individually and in combination for distinguishing malignant from benign masses. * Secondary outcomes: Agreement between modalities; correlation of specific imaging features with histopathology if available.

Data Analysis The collected data will be statistically analyzed using SPSS. Chi-square (X2 analysis) contingency analysis will be used. Results will be discussed. Conclusions and recommendations will be suggested based on the results.

Ethical Considerations

\- The study will be conducted in accordance with the Declaration of Helsinki. Informed consent will be obtained from all participants. The study protocol has been or will be approved by the \[Institutional Review Board/Ethics Committee\].

Interventions

  • Other Diagnostic imaging (US and MRI).
    Ultrasonography and MRI are performed as part of routine diagnostic evaluation, these are not therapeutic interventions

Primary outcome measures

  • Diagnostic accuracy of Ultrasound and MRI in characterization of superficial soft tissue masses. [Time frame: During initial diagnostic assessment]

Eligibility criteria

Inclusion criteria

  • Patients who suffer from superficial soft tissue lesions in both sex and of any age group, will be included in the study.

Exclusion criteria

  • Patients unwilling to complete study.
  • Patients with absolute or relative contraindications for imaging including; claustrophobia, metallic implants, pacemaker and prosthetic heart valves for MRI, will be evaluated by US.

Criteria are shown verbatim from the registry (in English). Final eligibility is always assessed by the study center.

Healthy volunteers: No

Study design

Observational model
Case-only

Study locations

Egypt · 1 center
  • Sohag University Hospital — Sohag

Identifiers

NCT: NCT07294248 · Soh-Med--25-11-15MS

Primary sources (government registries)

View this study on ClinicalTrials.gov ↗